Scribe Therapeutics, Inc. (SCTX) Insider Trading

Name: Scribe Therapeutics, Inc. (SCTX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jul 29, 2026): AH Bio Fund II, L.P. (10% Owner): Conversion of 2,051,742 shares.

Get alerted when insiders trade SCTX

Email address

Loading company data...

Beta

Loading company details...

Beta